108 related articles for article (PubMed ID: 15033547)
21. The effects of chorioamnionitis and betamethasone on 11beta hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta.
Johnstone JF; Bocking AD; Unlugedik E; Challis JR
J Soc Gynecol Investig; 2005 May; 12(4):238-45. PubMed ID: 15866114
[TBL] [Abstract][Full Text] [Related]
22. Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11β-hydroxysteroid dehydrogenase 1.
Nishihara M; Takahashi J; Kondo T; Mouri K; Asahi S
Drug Res (Stuttg); 2014 Sep; 64(9):476-84. PubMed ID: 24357138
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells.
Tsugita M; Iwasaki Y; Nishiyama M; Taguchi T; Shinahara M; Taniguchi Y; Kambayashi M; Terada Y; Hashimoto K
Life Sci; 2008 Sep; 83(11-12):426-32. PubMed ID: 18692075
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of 7beta-hydroxysteroid dehydrogenase from rabbit liver microsomes.
Shiotsuki H; Maeda Y; Chijiiwa K
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):185-90. PubMed ID: 15276626
[TBL] [Abstract][Full Text] [Related]
25. Central composite design as a powerful optimisation technique for enantioresolution of the rac-11-dihydrooracin--the principal metabolite of the potential cytostatic drug oracin.
Wsól V; Fell AF
J Biochem Biophys Methods; 2002 Dec; 54(1-3):377-90. PubMed ID: 12543513
[TBL] [Abstract][Full Text] [Related]
26. Implication of cortisol and 11beta-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts.
Sunak N; Green DF; Abeydeera LR; Thurston LM; Michael AE
Reproduction; 2007 Jun; 133(6):1149-58. PubMed ID: 17636169
[TBL] [Abstract][Full Text] [Related]
27. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
[TBL] [Abstract][Full Text] [Related]
28. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
Gong R; Morris DJ; Brem AS
Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis.
Claus R; Wagner A; Lambert T
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111
[TBL] [Abstract][Full Text] [Related]
30. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver.
Rekka EA; Soldan M; Belai I; Netter KJ; Maser E
Xenobiotica; 1996 Dec; 26(12):1221-9. PubMed ID: 9004452
[TBL] [Abstract][Full Text] [Related]
32. In vitro characterization of the enzymes involved in the metabolism of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound.
Lee SK; Kim JH; Seo YM; Kim HC; Kang MJ; Jeong HG; Lee ES; Jeong TC
Arch Pharm Res; 2008 Jun; 31(6):764-70. PubMed ID: 18563359
[TBL] [Abstract][Full Text] [Related]
33. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
Chapman KE; Coutinho A; Gray M; Gilmour JS; Savill JS; Seckl JR
Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
[TBL] [Abstract][Full Text] [Related]
34. Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation.
Patel JR; Shuai Q; Dinges J; Winn M; Pliushchev M; Fung S; Monzon K; Chiou W; Wang J; Pan L; Wagaw S; Engstrom K; Kerdesky FA; Longenecker K; Judge R; Qin W; Imade HM; Stolarik D; Beno DW; Brune M; Chovan LE; Sham HL; Jacobson P; Link JT
Bioorg Med Chem Lett; 2007 Feb; 17(3):750-5. PubMed ID: 17110106
[TBL] [Abstract][Full Text] [Related]
35. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
London E; Castonguay TW
J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
[TBL] [Abstract][Full Text] [Related]
36. Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand.
Skarydová L; Andrýs R; Holubová L; Stambergová H; Kňavová J; Wsól V; Bílková Z
J Sep Sci; 2013 Apr; 36(7):1176-84. PubMed ID: 23495195
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Trusselle M; Halem H; Culler MD; Potter BV
Mol Cell Endocrinol; 2009 Mar; 301(1-2):169-73. PubMed ID: 18775471
[TBL] [Abstract][Full Text] [Related]
38. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
Wamil M; Seckl JR
Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
[TBL] [Abstract][Full Text] [Related]
40. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli.
Blum A; Martin HJ; Maser E
Toxicology; 2000 Apr; 144(1-3):113-20. PubMed ID: 10781878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
